These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3031535)
1. Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol. Kataoka Y; Ohta H; Fujiwara M; Oishi R; Ueki S Neuropharmacology; 1987 Jan; 26(1):55-60. PubMed ID: 3031535 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Srinivasan J; Schmidt WJ Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological investigation on the role of dopamine in the rat locus coeruleus. Milon H; McRae-Degueurce A Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240 [TBL] [Abstract][Full Text] [Related]
4. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Srinivasan J; Schmidt WJ Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435 [TBL] [Abstract][Full Text] [Related]
5. Irritable aggression induced by delta 9-tetrahydrocannabinol in rats pretreated with 6-hydroxydopamine. Fujiwara M; Kataoka Y; Hori Y; Ueki S Pharmacol Biochem Behav; 1984 Mar; 20(3):457-62. PubMed ID: 6324245 [TBL] [Abstract][Full Text] [Related]
6. Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Prescott WR; Gold LH; Martin BR Psychopharmacology (Berl); 1992; 107(1):117-24. PubMed ID: 1317040 [TBL] [Abstract][Full Text] [Related]
7. Noradrenergic influences on catalepsy. Mason ST; Roberts DC; Fibiger HC Psychopharmacology (Berl); 1978 Dec; 60(1):53-7. PubMed ID: 104346 [TBL] [Abstract][Full Text] [Related]
8. Noradrenergic involvement in dopamine-dependent stereotyped and cataleptic responses in the rat. Pycock C Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):15-22. PubMed ID: 560634 [TBL] [Abstract][Full Text] [Related]
9. Suppression of noradrenergic innervation compensates for behavioral deficits induced by lesion of dopaminergic terminals in the lateral septum. Taghzouti K; Le Moal M; Simon H Brain Res; 1991 Jun; 552(1):124-8. PubMed ID: 1717110 [TBL] [Abstract][Full Text] [Related]
10. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of noradrenergic and dopaminergic nerves in the rat kidney: evidence against significant dopaminergic innervation. McGrath BP; Lim AE; Bode K; Willis GL; Smith GC Clin Exp Pharmacol Physiol; 1983; 10(5):543-53. PubMed ID: 6416723 [TBL] [Abstract][Full Text] [Related]
12. Effects of desipramine and maprotiline on the coeruleus-cortical noradrenergic system in anaesthetized rats. Ceci A; Borsini F Eur J Pharmacol; 1996 Sep; 312(2):189-93. PubMed ID: 8894595 [TBL] [Abstract][Full Text] [Related]
13. delta 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion. Sakurai Y; Ohta H; Shimazoe T; Kataoka Y; Fujiwara M; Ueki S Life Sci; 1985 Dec; 37(23):2181-5. PubMed ID: 2999542 [TBL] [Abstract][Full Text] [Related]
14. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy. Morelli M; Porceddu ML; Imperato A; Di Chiara G Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799 [TBL] [Abstract][Full Text] [Related]
15. Interaction between noradrenergic and serotonergic mechanisms on the central regulation of blood pressure in the rat: a study using experimental central hypertension produced by chemical lesions of the locus coeruleus. Ogawa M Jpn Circ J; 1978 May; 42(5):581-97. PubMed ID: 151755 [TBL] [Abstract][Full Text] [Related]
16. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Miller FE; Heffner TG; Kotake C; Seiden LS Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194 [TBL] [Abstract][Full Text] [Related]
18. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Heffner TG; Seiden LS Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184 [TBL] [Abstract][Full Text] [Related]
19. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat. Esposito E; Ossowska G; Samanin R Eur J Pharmacol; 1987 Apr; 136(3):429-32. PubMed ID: 3111866 [TBL] [Abstract][Full Text] [Related]
20. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain. Farooqui SM; Zhang K; Makhay M; Jackson K; Farooqui SQ; Cherry JA; O'Donnell JM Brain Res; 2000 Jun; 867(1-2):52-61. PubMed ID: 10837797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]